Skip to main content
VKTX logo

VKTX · Viking Therapeutics, Inc.

Track VKTX — free
$33.19 +0.25 (+0.76%) At close · Aug 14
Market Cap
$3.87B
Shares
116.65M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Brian Lian $21,269,833
Marianne Mancini $5,162,872
Greg Zante $5,135,872
Fiscal 2024
Executive Total
Brian Lian $14,298,554
Marianne Mancini $4,703,394
Greg Zante $4,681,394
Fiscal 2023
Executive Total
Brian Lian $12,628,061
Marianne Mancini $3,510,957
Greg Zante $3,495,957
Fiscal 2022
Executive Total
Brian Lian $5,411,291
Marianne Mancini $2,052,044
Greg Zante $1,710,661
Fiscal 2021
Executive Total
Brian Lian $4,059,119
Marianne Mancini $1,507,624
Greg Zante $1,345,330
Fiscal 2020
Executive Total
Brian Lian $5,187,448
Fiscal 2019
Executive Total
Brian Lian $3,512,119
Fiscal 2018
Executive Total
Brian Lian $1,403,283
Hiroko Masamune $992,924

Executive changes

Person Change Filed
Lawson Macartney, Ph.D. Appointed 2024-05-23
Brian Lian, Ph.D. Appointed 2024-05-23
Key facts CIK 1607678 CUSIP 92686J106 13F (30d) 402 filings 396 filers Visit website Investor relations